ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 837,40
0,86%
Dow Jones
44 156,73
0,30%
DAX
21 303,82
1,25%
Brent Oil
78,075
-0,33%
Bitcoin
102 002,08
-1,58%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Abivax SA (ABVX) Cours

Abivax SA

Abivax SA (ABVX)

Abivax
6,23
-0,14
(-2,20%)
Fermé 23 Janvier 10:00PM
Retardé de 15 minutes
6,23
0,00
(0,00%)
Après les heures de négociation: 12:01AM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
6,23
Prix Achat
2,54
Prix Vente
10,14
Volume échangé
61 737
6,17 Fourchette du Jour 6,55
0,00 Plage de 52 semaines 0,00
Cap du marché
391,976M
Clôture Veille
6,37
Ouverture
6,34
Dernière Transaction
75
@
6.25
Dernière heure de transaction
Volume financier
US$ 389 260
VWAP
6,3051
Volume moyen (3 m)
-
Actions en circulation
62 917 479
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-2,64
Bénéfice par action (BPA)
-2,35
Chiffre d'affairess
4,62M
Bénéfice net
-147,74M

À propos de Abivax SA

Abivax is focused on developing innovative treatments that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax is focused on developing innovative treatments that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.abivax.com
Siège social
Paris, Paris, Fra
Fondé
-
Abivax SA est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker ABVX. Le dernier cours de clôture d'Abivax était de US$6,37. Au cours de la dernière année, les actions de Abivax ont été négociées dans une fourchette de prix de US$ 0,00 à US$ 0,00.

Abivax compte actuellement 62 917 479 actions en circulation. La capitalisation boursière d'Abivax est de US$400,78 million. Abivax a un ratio cours/bénéfice (ratio PE) de -2.64.

ABVX Dernières nouvelles

Plus de nouvelles

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

10 Janvier 2025
Edgar (US Regulatory)

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment

Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment Phase 3 ABTECT Trial evaluating obefazimod for moderately to severely active ulcerative colitis (“UC”) reaches 1,003 of 1,224...

09 Janvier 2025
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

23 Décembre 2024
Edgar (US Regulatory)

Abivax Announces a Change to the Composition of its Board of Directors

Abivax Announces a Change to the Composition of its Board of Directors PARIS, France, December 23, 2024, 10:05 PM CEST – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the...

23 Décembre 2024
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

27 Novembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

19 Novembre 2024
Edgar (US Regulatory)

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq

Abivax Establishes an At-the-Market (ATM) Program on Nasdaq PARIS, France, November 19, 2024 – 10:30PM CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq - ABVX) (“Abivax” or the...

19 Novembre 2024
GlobeNewswire Inc.

Form F-3 - Registration statement by foreign private issuers

19 Novembre 2024
Edgar (US Regulatory)

Abivax presents third quarter 2024 key financial information

Abivax presents third quarter 2024 key financial information PARIS, France, November 14, 2024, 10:00 p.m. CET – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the...

14 Novembre 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

14 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

ABVX - Frequently Asked Questions (FAQ)

What is the current Abivax share price?
The current share price of Abivax is US$ 6,23
How many Abivax shares are in issue?
Abivax has 62 917 479 shares in issue
What is the market cap of Abivax?
The market capitalisation of Abivax is USD 400,78M
What is the 1 year trading range for Abivax share price?
Abivax has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Abivax?
The price to earnings ratio of Abivax is -2,64
What is the cash to sales ratio of Abivax?
The cash to sales ratio of Abivax is 84,47
What is the reporting currency for Abivax?
Abivax reports financial results in EUR
What is the latest annual turnover for Abivax?
The latest annual turnover of Abivax is EUR 4,62M
What is the latest annual profit for Abivax?
The latest annual profit of Abivax is EUR -147,74M
What is the registered address of Abivax?
The registered address for Abivax is 7-11 BOULEVARD HAUSSMANN, PARIS, PARIS, 75009
What is the Abivax website address?
The website address for Abivax is www.abivax.com
Which industry sector does Abivax operate in?
Abivax operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
BLBXBlackBoxStocks Inc
US$ 5,53
(227,22%)
229,08M
ASSTAsset Entities Inc
US$ 1,36
(51,11%)
121,68M
STAIScanTech AI Systems Inc
US$ 2,12
(44,22%)
51,68M
JYDJayud Global Logistics Ltd
US$ 3,53
(42,91%)
1,27M
NTRBNutriband Inc
US$ 7,39
(41,84%)
3,88M
STFSStar Fashion Culture Holdings Ltd
US$ 2,62
(-80,61%)
30,25M
HEPAHepion Pharmaceuticals Inc
US$ 0,135
(-58,05%)
39,89M
STBXStarBox Group Holdings Ltd
US$ 0,6201
(-36,50%)
1,63M
WHLRLWheeler Real Estate Investment Trust Inc
US$ 93,51
(-35,73%)
1
JUNSJupiter Neurosciences Inc
US$ 3,61
(-33,39%)
6,87M
IPAImmunoPrecise Antibodies Ltd
US$ 0,6446
(30,75%)
296,43M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,3191
(33,57%)
229,11M
BLBXBlackBoxStocks Inc
US$ 5,53
(227,22%)
229,08M
NVDANVIDIA Corporation
US$ 147,07
(4,43%)
216,62M
RGTIRigetti Computing Inc
US$ 13,89
(-0,64%)
154,54M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
ABVX
Abivax
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés